This book provides readers a fundamental insight into the basic
properties of the pharmaceutical agents used in the treatment of
osteoporosis. It provides insight into mechanisms of action,
updated information on clinical utility, and possible side effects
associated with the use of these pharmaceutical agents. In
particular, it highlights the use of two monoclonal antibodies
romosozumab and denosumab in activating osteoblast differentiation
and inhibiting osteoclasts. It also discusses two anabolic
pharmaceutical agents, teriparatide and abaloparatide to treat
osteoporosis. They have been shown to reduce the incidence of
non-vertebral and vertebral fractures significantly after they were
administered to patients daily as subcutaneous injections. The
content of this book caters to researchers, scientists, and
clinical practitioners who are interested in the treatment of
osteoporosis using pharmaceutical agents.
General
| Imprint: |
Springer Verlag, Singapore
|
| Country of origin: |
Singapore |
| Series: |
Tissue Repair and Reconstruction |
| Release date: |
October 2023 |
| First published: |
2024 |
| Editors: |
Andy H. Choi
• Sian Yik Lim
|
| Dimensions: |
235 x 155mm (L x W) |
| Pages: |
96 |
| Edition: |
1st ed. 2024 |
| ISBN-13: |
978-981-9958-25-2 |
| Categories: |
Books
|
| LSN: |
981-9958-25-3 |
| Barcode: |
9789819958252 |
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
Welcome to Loot.co.za!
Sign in / Register |Wishlists & Gift Vouchers |Help | Advanced search
